Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty
Launched by UNIVERSITY OF COLORADO, DENVER · Apr 29, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a treatment called neuromuscular electrical stimulation (NMES) to help patients recover after total knee replacement surgery. Many patients lose strength in their thigh muscles (quadriceps) after the surgery, which can make it harder to move around and regain function. The trial aims to see how effective and practical it is to use NMES in rehabilitation programs at two large healthcare organizations. NMES could help improve muscle strength and overall recovery for patients.
To be eligible for this trial, participants should be between the ages of 65 and 74 and have recently undergone knee replacement surgery on one knee. They must be able to use an NMES unit within a week after their surgery and attend physical therapy sessions at one of the participating clinics. Participants will need to attend at least three physical therapy visits as part of their recovery. It's important for potential participants to know that those with certain health conditions, like having an implanted heart device or recent blood clots, cannot join the trial. If you meet the criteria and are interested, this study could provide valuable insights into improving recovery after knee surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Site Inclusion Criteria:
- • • UCHealth or Intermountain Health outpatient physical therapy clinic
- Patient Inclusion Criteria:
- • Underwent primary unilateral TKA
- • Used NMES unit within 7 days after TKA and attended outpatient rehabilitation at a participating clinic within 14 days after TKA
- • Attended at least 3 total outpatient physical therapy visits in total
- Exclusion Criteria:
- Patient Exclusion Criteria:
- • • NMES Contraindications \[Patients with implanted cardiovascular cardiovertedefibrillator (ICD), active cancer, post-operative diagnosed deep vein thrombosis (DVT) in involved lower extremity\]
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Murray, Utah, United States
Aurora, Colorado, United States
Aurora, Colorado, United States
Patients applied
Trial Officials
Jennifer Stevens-Lapsley, PT, PhD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported